Cite
HARVARD Citation
Richard, F. et al. (2014). FRI0389 Effects of Chronic Treatment with Subcutaneous Blisibimod on Renal and Inflammation Biomarkers in Subjects with Systemic Lupus Erythematosus in Phase 2 PEARL-SC and Open-Label Extension Studies. Annals of the rheumatic diseases. p. 528. [Online].